📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cargo Therapeutics

1.1 - Company Overview

Cargo Therapeutics Logo

Cargo Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of CAR T-cell therapies and platforms to overcome cancer treatment resistance and address access barriers. Products include CRG-022 (Firi-cel), a CD22-targeted CAR T for large B-cell lymphoma refractory or relapsed after CD19 CAR T; CRG-023, a tri-specific CAR T targeting CD19/CD20/CD22 with CD2 co-stimulation; a CD2 platform for activation in CD58-lacking tumors; and the STASH platform for multi-gene CAR T engineering.

Products and services

  • CRG-023: Custom-engineered CAR T-cell system with CD2 co-stimulation, tri-specifically targeting CD19, CD20, and CD22 to treat various B-cell malignancies
  • CRG-022 (Firi-cel): Precision-engineered CAR T-cell product targeting CD22 for large B-cell lymphoma refractory or relapsed after prior CD19 CAR T-cell therapy
  • CD2 Platform: Modular technology integrating a CD2 costimulatory domain to enhance CAR T-cell activation against tumors lacking CD58 expression

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cargo Therapeutics

Mevion Medical Systems Logo

Mevion Medical Systems

HQ: United States Website
  • Description: Provider of innovative, safe, and effective radiation therapy solutions for the treatment of cancer, pioneering modern proton therapy systems and transforming advances in medical technology and science into practical clinical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mevion Medical Systems company profile →
IDRx Logo

IDRx

HQ: United States Website
  • Description: Provider of oncology-based precision therapies for gastrointestinal stromal tumors (GIST). The clinical-stage biopharma designs precision combination medicines with engineered drug combinations to stop key tumor escape mechanisms and prolong response. Pipeline includes IDRX-42, a Phase 1 small-molecule tyrosine kinase inhibitor targeting genetic drivers and resistance mutations in GIST, and IDRX-73 targeting a key drug resistance mutation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IDRx company profile →
Aegera Therapeutics Logo

Aegera Therapeutics

HQ: Canada Website
  • Description: Provider of clinical-stage targeted therapeutics addressing major unmet medical needs, with three programs in clinical development—two in oncology and one in neuropathic pain—and ongoing identification of novel development candidates based on core technologies. Part of Pharmascience Inc.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aegera Therapeutics company profile →
Transgene Logo

Transgene

HQ: France Website
  • Description: Provider of integrated immunotherapies to treat cancers and chronic infectious diseases, covering research, clinical batch manufacturing, and clinical trials. Portfolio includes TG4050 personalized neoantigen cancer vaccine using genetic engineering and AI; TG4001 therapeutic HPV-16 cancer vaccine; BT-001 (anti-CTLA4, GM-CSF) and TG6050 (IL-12, anti-CTLA4) oncolytic viruses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Transgene company profile →
IONIQ Sciences Logo

IONIQ Sciences

HQ: United States Website
  • Description: Provider of solutions for early detection of multiple cancers to improve survivability and reduce healthcare costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IONIQ Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cargo Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cargo Therapeutics

2.2 - Growth funds investing in similar companies to Cargo Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cargo Therapeutics

4.2 - Public trading comparable groups for Cargo Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cargo Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cargo Therapeutics

What does Cargo Therapeutics do?

Cargo Therapeutics is a provider of CAR T-cell therapies and platforms to overcome cancer treatment resistance and address access barriers. Products include CRG-022 (Firi-cel), a CD22-targeted CAR T for large B-cell lymphoma refractory or relapsed after CD19 CAR T; CRG-023, a tri-specific CAR T targeting CD19/CD20/CD22 with CD2 co-stimulation; a CD2 platform for activation in CD58-lacking tumors; and the STASH platform for multi-gene CAR T engineering.

Who are Cargo Therapeutics's competitors?

Cargo Therapeutics's competitors and similar companies include Mevion Medical Systems, IDRx, Aegera Therapeutics, Transgene, and IONIQ Sciences.

Where is Cargo Therapeutics headquartered?

Cargo Therapeutics is headquartered in United States.

How many employees does Cargo Therapeutics have?

Cargo Therapeutics has 1,000 employees 🔒.

When was Cargo Therapeutics founded?

Cargo Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Cargo Therapeutics in?

Cargo Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cargo Therapeutics

Who are the top strategic acquirers in Cargo Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Cargo Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cargo Therapeutics?

Top strategic M&A buyers groups and sectors for Cargo Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cargo Therapeutics's sector and industry vertical

Which are the top PE firms investing in Cargo Therapeutics's sector and industry vertical?

Top PE firms investing in Cargo Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cargo Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cargo Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cargo Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cargo Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cargo Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cargo Therapeutics?

The key public trading comparables and valuation benchmarks for Cargo Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cargo Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cargo Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cargo Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cargo Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cargo Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Cargo Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cargo Therapeutics

Launch login modal Launch register modal